Market Cap

Caplin Point Laboratories Ltd Market Capitalization:

₹111.79 Billion

INR as of July 1, 2024

US$1.34 Billion

business Caplin Point Laboratories Ltd Company Profile

Caplin Point Laboratories Ltd Main Stock Listing

NSE: CAPLIPOINT

Market Capitalization History of Caplin Point Laboratories Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $80.13 B
MERCK Kommanditgesellschaft auf Aktien $71.24 B
Takeda Pharmaceutical Company Limited $41.23 B
Haleon plc $37.32 B
Teva Pharmaceutical Industries Limited $18.88 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Caplin Point Laboratories Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2024 ₹106.30 B 96.54%
Jan. 1, 2023 ₹54.08 B -10.34%
Jan. 1, 2022 ₹60.32 B 73.05%
Jan. 1, 2021 ₹34.86 B 59.63%
Jan. 1, 2020 ₹21.84 B -20.74%
Jan. 1, 2019 ₹27.55 B -38.43%
Jan. 1, 2018 ₹44.75 B 39.99%
Jan. 1, 2017 ₹31.96 B 74.80%
Jan. 1, 2016 ₹18.29 B 100.62%
Jan. 1, 2015 ₹9.11 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Caplin Point Laboratories Ltd Categories

India languages Healthcare languages Drug Manufacturers—Specialty & Generic
India Healthcare India Drug Manufacturers—Specialty & Generic

Stocks & Indices

Caplin Point Laboratories Ltd has the following listings and related stock indices.


Stock: NSE: CAPLIPOINT

Stock: BSE: CAPPL

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.